Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer
David A Proia, Chaohua Zhang, Manuel Sequeira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 7, 2018
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)
Anna S Nikonova, Alexander Y Deneka, Anna A Kiseleva, et al.
Molecular Cancer Therapeutics
|
December 7, 2011
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy
Weiwen Ying, Zhenjian Du, Lijun Sun, et al.
Angiogenesis
|
July 11, 2013
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
Ganji Purnachandra Nagaraju, Purnachandra Nagaraju Ganji, Wungki Park, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models
Danlin Sun, Anna S Nikonova, Peishan Zhang, et al.
Blood
|
July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
Hima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2016
A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
Anna V Gaponova, Anna S Nikonova, Alexander Deneka, et al.
Molecular Cancer Therapeutics
|
August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors
David A Proia, Donald L Smith, Junyi Zhang, et al.
Cell Reports
|
July 12, 2016
Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer
Tim N Beck, Vladislav A Korobeynikov, Alexander E Kudinov, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination
Ellen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer
David A Proia, Chaohua Zhang, Manuel Sequeira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 7, 2018
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)
Anna S Nikonova, Alexander Y Deneka, Anna A Kiseleva, et al.
Molecular Cancer Therapeutics
|
December 7, 2011
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy
Weiwen Ying, Zhenjian Du, Lijun Sun, et al.
Angiogenesis
|
July 11, 2013
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
Ganji Purnachandra Nagaraju, Purnachandra Nagaraju Ganji, Wungki Park, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models
Danlin Sun, Anna S Nikonova, Peishan Zhang, et al.
Blood
|
July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
Hima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2016
A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
Anna V Gaponova, Anna S Nikonova, Alexander Deneka, et al.
Molecular Cancer Therapeutics
|
August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors
David A Proia, Donald L Smith, Junyi Zhang, et al.
Cell Reports
|
July 12, 2016
Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer
Tim N Beck, Vladislav A Korobeynikov, Alexander E Kudinov, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination
Ellen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Page
of 5